Covishield vaccine 63.1% effective on Covid-19 delta variant: THSTI study
Researchers at Translational Health Science and Technology Institute (THSTI) evaluated the real-world vaccine effectiveness of Covishield during the SARS-CoV-2 infection surge between April and May, 2021, in India